Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Lars Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine · 2009 · 7K citations · Full text

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Steen Husted, Håkan Emanuelsson, Stan Heptinstall et al. · European Heart Journal · 2006 · 738 citations · Full text

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Christopher P. Cannon, Steen Husted, Robert A. Harrington et al. · Journal of the American College of Cardiology · 2007 · 490 citations

Molecular Pharmacology, Thrombosis, Cardiovascular Disease +11

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

Stefan James, Axel Åkerblom, Christopher P. Cannon et al. · American Heart Journal · 2009 · 400 citations

Thrombosis, Platelet Aggregation Inhibitors, Cardiovascular Disease +12

Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects

Renli Teng, Stuart Oliver, Martin A. Hayes et al. · Drug Metabolism and Disposition · 2010 · 260 citations